Zusammenfassung
Hintergrund
Die diabetische Neuropathie ist eine typische Komplikation des Diabetes mellitus. Während die häufigste distal-symmetrische Form meist sicher diagnostiziert werden kann, werfen die selteneren Formen der diabetischen Neuropathie differenzialdiagnostische Probleme auf, eröffnen aber oft eigenständige Behandlungsmöglichkeiten zusätzlich zur verbesserten Blutzuckerkontrolle.
Ziel der Arbeit
Diese Übersichtsarbeit soll einen Überblick über die selteneren Formen der diabetischen Neuropathie, ihren Stellenwert sowie diagnostische und therapeutische Möglichkeiten geben.
Ergebnisse
Vorgestellt werden die autonome diabetische Neuropathie, die Small-fiber-Neuropathie bei Diabetes mellitus und die seltenen Formen, wie diabetische Radikuloplexopathie, die diabetische Neuropathie der Hirnnerven, die therapieinduzierte Neuropathie und alternative Neuropathieursachen bei Diabetikern.
Diskussion
Die Diagnostik der selteneren Neuropathieformen und speziell ihre Abgrenzung gegenüber alternativen Neuropathieursachen bereitet in der Praxis häufig Schwierigkeiten. Diese Übersichtsarbeit soll den Umgang mit verschiedenen Formen der diabetischen Neuropathie erleichtern und Hilfestellung in der Erkennung alternativer Neuropathieursachen geben.
Summary
Background
Diabetic neuropathy is a common complication of diabetes mellitus. The length-dependent symmetrical sensorimotor type of neuropathy is the most prevalent form of diabetic neuropathy but other forms of diabetic neuropathy also need to be kept in mind. Their differential diagnosis is often more challenging but implicates specific forms of treatment other than improvement of metabolic control.
Aim of the study
This article gives an overview of the less frequent forms of diabetic neuropathy and discusses their impact, diagnostic and therapeutic implications.
Results
Autonomic diabetic neuropathy, diabetic small fiber neuropathy and less frequent forms of diabetic neuropathy, such as diabetic radiculoplexopathy, diabetic neuropathy of cranial nerves, therapy-induced neuropathy and alternative causes of peripheral neuropathy in patients with diabetes are described.
Discussion
Diagnosis of less frequent subtypes of diabetic neuropathy and differentiation towards alternative causes of peripheral neuropathy are often difficult in daily medical routine. Diagnostic clues are helpful in identifying rarer forms of diabetic neuropathy, thus enabling more specific treatment.
Literatur
Asbury AK, Aldredge H, Hershberg R et al (1970) Oculomotor palsy in diabetes mellitus: a clinico-pathological study. Brain 93:555–566
Boussageon R, Gueyffier F, Cornu C (2014) Effects of pharmacological treatments on micro- and macrovascular complications of type 2 diabetes: what is the level of evidence? Diabetes Metab 40:169–175
Bundesärztekammer (BÄK) KBK, Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (AWMF) (2011) Nationale VersorgungsLeitlinie Neuropathie bei Diabetes im Erwachsenenalter – Langfassung. Version 1.X. http://wwwdiabetesversorgungsleitliniende, http://wwwversorgungsleitliniende, http://wwwawmf-leitliniende
Burgos LG, Ebert TJ, Asiddao C et al (1989) Increased intraoperative cardiovascular morbidity in diabetics with autonomic neuropathy. Anesthesiology 70:591–597
Chio A, Plano F, Calvo A et al (2009) Comorbidity between CIDP and diabetes mellitus: only a matter of chance? Eur J Neurol 16:752–754
Coppack SW, Watkins PJ (1991) The natural history of diabetic femoral neuropathy. Q J Med 79:307–313
Dabby R, Sadeh M, Lampl Y et al (2009) Acute painful neuropathy induced by rapid correction of serum glucose levels in diabetic patients. Biomed Pharmacother 63:707–709
Deli G, Bosnyak E, Pusch G et al (2013) Diabetic neuropathies: diagnosis and management. Neuroendocrinology 98:267–280
Dotson S, Freeman R, Failing HJ et al (2008) Hypoglycemia increases serum interleukin-6 levels in healthy men and women. Diabetes Care 31:1222–1223
Dunnigan SK, Ebadi H, Breiner A et al (2014) The characteristics of chronic inflammatory demyelinating polyneuropathy in patients with and without diabetes – an observational study. PLoS One 9:e89344
Dyck PJ, Norell JE (1999) Microvasculitis and ischemia in diabetic lumbosacral radiculoplexus neuropathy. Neurology 53:2113–2121
Dyck PJ, Norell JE (2001) Non-diabetic lumbosacral radiculoplexus neuropathy: natural history, outcome and comparison with the diabetic variety. Brain 124:1197–1207
Dyck PJ, Windebank AJ (2002) Diabetic and nondiabetic lumbosacral radiculoplexus neuropathies: new insights into pathophysiology and treatment. Muscle Nerve 25:477–491
Joint Task Force of the EFNS and PNS (2010) European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of multifocal motor neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society – first revision. J Peripher Nerv Syst 15:295–301
Fullerton B, Jeitler K, Seitz M et al (2014) Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus. Cochrane Database Syst Rev 2:CD009122
Gibbons CH, Freeman R (2010) Treatment-induced diabetic neuropathy: a reversible painful autonomic neuropathy. Ann Neurol 67:534–541
Gorson KC, Ropper AH (2006) Additional causes for distal sensory polyneuropathy in diabetic patients. J Neurol Neurosurg Psychiatry 77:354–358
Hilsted J, Parving HH, Christensen NJ et al (1981) Hemodynamics in diabetic orthostatic hypotension. J Clin Invest 68:1427–1434
Jacobson DM (1998) Pupil involvement in patients with diabetes-associated oculomotor nerve palsy. Arch Ophthalmol 116:723–727
Jann S, Bramerio MA, Facchetti D et al (2009) Intravenous immunoglobulin is effective in patients with diabetes and with chronic inflammatory demyelinating polyneuropathy: long term follow-up. J Neurol Neurosurg Psychiatry 80:70–73
Jenkins PJ, Duckworth AD, Watts AC et al (2012) The outcome of carpal tunnel decompression in patients with diabetes mellitus. J Bone Joint Surg Br 94:811–814
Kunesch E, Reiners K (1989) A simple method for the routine assessment of heart-rate variation in autonomic neuropathy. Electromyogr Clin Neurophysiol 29:293–297
Kunesch E, Reiners K, Müller-Mattheis V et al (1992) Neurological risk profile in organic erectile impotence. J Neurol Neurosurg Psychiatry 55:275–281
Laughlin RS, Dyck PJ, Melton LJ III et al (2009) Incidence and prevalence of CIDP and the association of diabetes mellitus. Neurology 73:39–45
Lauria G, Hsieh ST, Johansson O et al (2010) European Federation of Neurological Societies/Peripheral Nerve Society Guideline on the use of skin biopsy in the diagnosis of small fiber neuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. Eur J Neurol 17:903–912, e944–e909
Loseth S, Stalberg E, Jorde R et al (2008) Early diabetic neuropathy: thermal thresholds and intraepidermal nerve fibre density in patients with normal nerve conduction studies. J Neurol 255:1197–1202
Lozeron P, Nahum L, Lacroix C et al (2002) Symptomatic diabetic and non-diabetic neuropathies in a series of 100 diabetic patients. J Neurol 249:569–575
Massie R, Mauermann ML, Staff NP et al (2012) Diabetic cervical radiculoplexus neuropathy: a distinct syndrome expanding the spectrum of diabetic radiculoplexus neuropathies. Brain 135:3074–3088
Ohshima J, Nukada H (2002) Hypoglycaemic neuropathy: microvascular changes due to recurrent hypoglycaemic episodes in rat sciatic nerve. Brain Res 947:84–89
Rage M, Van Acker N, Knaapen MW et al (2011) Asymptomatic small fiber neuropathy in diabetes mellitus: investigations with intraepidermal nerve fiber density, quantitative sensory testing and laser-evoked potentials. J Neurol 258:1852–1864
Razavi Nematollahi L, Kitabchi AE, Stentz FB et al (2009) Proinflammatory cytokines in response to insulin-induced hypoglycemic stress in healthy subjects. Metabolism 58:443–448
Rush JA, Younge BR (1981) Paralysis of cranial nerves III, IV, and VI. Cause and prognosis in 1,000 cases. Arch Ophthalmol 99:76–79
Said G (2007) Diabetic neuropathy – a review. Nat Clin Pract Neurol 3:331–340
Sharma KR, Cross J, Farronay O et al (2002) Demyelinating neuropathy in diabetes mellitus. Arch Neurol 59:758–765
Shun CT, Chang YC, Wu HP et al (2004) Skin denervation in type 2 diabetes: correlations with diabetic duration and functional impairments. Brain 127:1593–1605
Spallone V, Ziegler D, Freeman R et al (2011) Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev 27(7):639–653
Tamburin S, Zanette G (2009) Intravenous immunoglobulin for the treatment of diabetic lumbosacral radiculoplexus neuropathy. Pain Med 10:1476–1480
Tesfaye S, Malik R, Harris N et al (1996) Arterio-venous shunting and proliferating new vessels in acute painful neuropathy of rapid glycaemic control (insulin neuritis). Diabetologia 39:329–335
Thaisetthawatkul P, Dyck PJ (2010) Treatment of diabetic and nondiabetic lumbosacral radiculoplexus neuropathy. Curr Treat Options Neurol 12:95–99
Thomsen NO, Cederlund R, Rosen I et al (2009) Clinical outcomes of surgical release among diabetic patients with carpal tunnel syndrome: prospective follow-up with matched controls. J Hand Surg Am 34:1177–1187
Umapathi T, Tan WL, Loke SC et al (2007) Intraepidermal nerve fiber density as a marker of early diabetic neuropathy. Muscle Nerve 35:591–598
Vinik AI, Erbas T (2001) Recognizing and treating diabetic autonomic neuropathy. Cleve Clin J Med 68:928–930, 932, 934–944
Vinik AI, Freeman R, Erbas T (2003) Diabetic autonomic neuropathy. Semin Neurol 23:365–372
Wile DJ, Toth C (2010) Association of metformin, elevated homocysteine, and methylmalonic acid levels and clinically worsened diabetic peripheral neuropathy. Diabetes Care 33:156–161
Wilson JR, Stittsworth JD Jr, Kadir A et al (1998) Conduction velocity versus amplitude analysis: evidence for demyelination in diabetic neuropathy. Muscle Nerve 21:1228–1230
Einhaltung ethischer Richtlinien
Interessenkonflikt. K. Doppler: Vortragstätigkeiten für Baxter, Reisekostenerstattung durch Eli Lilly, Pfizer und Orion Pharma. K. Reiners erklärt, dass er Vortragshonorare erhalten hat von den Firmen Baxter Deutschland GmbH, MerckSerono GmbH, Pfizer GmbH und Wörwag Pharma GmbH. Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Doppler, K., Reiners , K. Diabetische Neuropathie. Nervenarzt 86, 161–166 (2015). https://doi.org/10.1007/s00115-014-4127-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00115-014-4127-2